AIM β’ KMU EXAM REASONING
KMU Past Paper Practice
Topic 3 β Myeloid Neoplasms, Myelodysplastic Syndromes and Myeloproliferative Disorders
3rd Year MBBS β’ 20 A-type Single Best Answer MCQs :contentReference[oaicite:0]{index=0}
MCQ 1
Question:
Bone-marrow examination in a 54-year-old patient with acute leukemia shows abnormal cells demonstrating both granulocytic and monocytic differentiation. Which FAB category best fits this pattern?
Options:
M1 β AML without maturation
M3 β Acute promyelocytic leukemia
M4 β Acute myelomonocytic leukemia
M5 β Acute monocytic leukemia
M7 β Acute megakaryoblastic leukemia
Correct Answer: M4 β Acute myelomonocytic leukemia
Explanation: FAB M4 shows differentiation along both granulocytic and monocytic pathways, distinguishing it from predominantly monocytic M5 disease.
MCQ 2
Question:
A patient with acute myeloid leukemia has blasts showing differentiation toward platelet-producing cells. Which FAB subtype corresponds to this finding?
Correct Answer: M7
Explanation: FAB M7 is acute megakaryoblastic leukemia, in which the leukemic blasts demonstrate megakaryocytic differentiation.
MCQ 3
Question:
A 66-year-old man has fatigue, bruising and anemia. His total leukocyte count is within the reference range, but bone marrow contains a large population of myeloid blasts. Which interpretation is most appropriate?
Options:
AML can be present despite a normal total leukocyte count
AML requires marked leukocytosis in peripheral blood
The marrow findings indicate secondary erythrocytosis
Normal leukocyte numbers exclude marrow neoplasia
The findings are characteristic of reactive neutrophilia
Correct Answer: AML can be present despite a normal total leukocyte count
Explanation: Peripheral leukocyte counts in AML may be increased, normal or reduced; marrow blast accumulation is therefore more important than the total count alone.
MCQ 4
Question:
Morphology and lineage studies have established AML in a 49-year-old patient. Cytogenetic and molecular studies are then requested. What is their most important additional contribution?
Options:
Determine circulating plasma volume
Measure neutrophil phagocytic activity
Assess renal erythropoietin production
Define biologically important disease subtypes
Estimate peripheral platelet survival
Correct Answer: Define biologically important disease subtypes
Explanation: Cytogenetic and molecular abnormalities help classify AML into biologically meaningful subtypes after leukemia and lineage have been established.
MCQ 5
Question:
Bone marrow from a patient with AML contains many myeloblasts, but a significant proportion of leukemic cells also mature toward later granulocytic forms. Which FAB category best fits this pattern?
Correct Answer: M2
Explanation: FAB M2 represents AML with maturation, whereas M1 is characterized by much less differentiation beyond the blast stage.
MCQ 6
Question:
Cytogenetic analysis in a patient with a chronic myeloproliferative disorder demonstrates t(9;22). Which chromosomal structure is conventionally called the Philadelphia chromosome?
Options:
Derivative chromosome 9
Derivative chromosome 22
Deleted chromosome 5
Derivative chromosome 15
Duplicated chromosome 17
Correct Answer: Derivative chromosome 22
Explanation: The Philadelphia chromosome is the shortened derivative chromosome 22 produced by the reciprocal translocation between chromosomes 9 and 22.
MCQ 7
Question:
A 45-year-old man has marked leukocytosis, splenomegaly and a blood film strongly suggestive of CML. Conventional chromosome analysis is inconclusive. Which study would most directly confirm the suspected disease-driving abnormality?
Options:
Serum ferritin assay
Reticulocyte percentage
Serum erythropoietin assay
FISH or molecular testing for BCR::ABL1
Platelet aggregation study
Correct Answer: FISH or molecular testing for BCR::ABL1
Explanation: Demonstration of the BCR::ABL1 fusion by FISH or molecular methods can confirm CML when conventional cytogenetic assessment is insufficient.
MCQ 8
Question:
A patient with chronic-phase CML initially receives imatinib but develops intolerance while the disease remains suitable for molecularly targeted treatment. Which management principle is most appropriate?
Options:
Use another BCR::ABL1 tyrosine-kinase inhibitor
Replace therapy with erythropoietin alone
Use filgrastim as definitive antileukemic therapy
Treat the disease with platelet transfusions alone
Stop targeted therapy without replacement
Correct Answer: Use another BCR::ABL1 tyrosine-kinase inhibitor
Explanation: Other BCR::ABL1 inhibitors can be selected when imatinib is not tolerated or becomes unsuitable, while preserving targeted suppression of the leukemic driver.
MCQ 9
Question:
Bone marrow is examined in a patient with chronic-phase CML who has marked peripheral leukocytosis. Which marrow pattern is most consistent with the disease at this stage?
Options:
Profound hypocellularity of all lineages
Selective lymphoid proliferation
Isolated erythroid aplasia
Complete replacement by plasma cells
Marked granulocytic hyperplasia
Correct Answer: Marked granulocytic hyperplasia
Explanation: Chronic-phase CML produces a markedly hypercellular marrow dominated by expansion of the granulocytic series.
MCQ 10
Question:
A 69-year-old woman has persistent macrocytic anemia and morphological dysplasia. Cytogenetic analysis identifies an isolated deletion involving the long arm of chromosome 5. Which MDS category best matches this finding?
Options:
MDS with excess blasts
MDS with ring sideroblasts
MDS with isolated del(5q)
MDS with multilineage dysplasia
MDS with single-lineage dysplasia
Correct Answer: MDS with isolated del(5q)
Explanation: An isolated deletion of chromosome 5q defines an important MDS category and represents a clonal cytogenetic abnormality.
MCQ 11
Question:
A 73-year-old man with a myelodysplastic syndrome has anemia with enlarged red cells. Bone marrow shows irregular erythroid precursors with disturbed development. Which process best explains these findings?
Options:
Selective granulocyte destruction
Increased peripheral red-cell loss
Autonomous erythropoietin production
Abnormal erythroid maturation
Isolated megakaryocyte proliferation
Correct Answer: Abnormal erythroid maturation
Explanation: Dysplastic erythropoiesis in MDS can produce macrocytic circulating red cells together with abnormal erythroid precursors in the marrow.
MCQ 12
Question:
A patient with MDS has thrombocytopenia. Peripheral blood shows unusually large, poorly granulated platelets, while marrow examination demonstrates abnormal platelet-forming cells. Which pathological process is responsible?
Options:
Granulocytic hyperplasia
Megakaryocytic dysplasia
Erythroid hyperplasia
Lymphoid proliferation
Monocytic expansion
Correct Answer: Megakaryocytic dysplasia
Explanation: MDS may produce structurally abnormal megakaryocytes and platelets, reflecting dysplastic maturation of the megakaryocytic lineage.
MCQ 13
Question:
Persistent unexplained cytopenias and abnormal blood-cell morphology raise suspicion of MDS in a 71-year-old patient. Which set of features should be specifically assessed during marrow examination to support diagnosis and classification?
Options:
Plasma volume, iron stores and clotting time
Lymph-node size, spleen size and liver enzymes
Erythropoietin level, oxygen saturation and ferritin
Neutrophil count, reticulocyte count and bleeding time
Cellularity, dysplasia and blast proportion
Correct Answer: Cellularity, dysplasia and blast proportion
Explanation: Marrow cellularity, the extent and lineages of dysplasia, and blast proportion are central to morphological assessment of suspected MDS.
MCQ 14
Question:
A 64-year-old man with polycythemia vera develops recurrent attacks of acute joint pain due to urate crystal deposition. Which feature of his hematological disorder most directly contributes to this complication?
Options:
Increased nucleic-acid breakdown from high blood-cell turnover
Reduced platelet production in the bone marrow
Failure of granulocytic differentiation
Loss of circulating lymphocytes
Suppression of plasma-cell function
Correct Answer: Increased nucleic-acid breakdown from high blood-cell turnover
Explanation: Increased turnover of the expanded blood-cell mass raises purine breakdown and uric-acid production, predisposing to hyperuricemia and gout.
MCQ 15
Question:
A patient with long-standing polycythemia vera later develops worsening anemia, increasing splenic enlargement and progressive fibrotic replacement of the bone marrow. Which change in the clinical course has occurred?
Options:
Development of reactive erythrocytosis
Conversion to isolated thrombocytosis
Progression to marrow fibrosis
Development of transient neutropenia
Resolution of the myeloproliferative clone
Correct Answer: Progression to marrow fibrosis
Explanation: Polycythemia vera may evolve over time into a fibrotic phase, producing worsening marrow function and increasing extramedullary hematopoiesis.
MCQ 16
Question:
A 59-year-old man is being evaluated for persistent erythrocytosis. Which additional complete blood count pattern would more strongly suggest a clonal myeloproliferative process rather than an isolated increase in red-cell production?
Options:
Reduced lymphocytes with normal platelets
Normal leukocytes with reduced platelets
Reduced neutrophils with normal monocytes
Isolated anemia with reticulocytosis
Leukocytosis with thrombocytosis
Correct Answer: Leukocytosis with thrombocytosis
Explanation: Polycythemia vera arises from the myeloid stem-cell compartment, so granulocytes and platelets may increase along with red cells rather than erythrocytes increasing alone.
MCQ 17
Question:
A patient receives filgrastim following myelosuppressive treatment. Which marrow response most directly accounts for the expected improvement in the circulating neutrophil count?
Options:
Suppression of granulocyte progenitor division
Stimulation of neutrophil precursor proliferation and maturation
Selective activation of erythroid precursors
Inhibition of monocyte differentiation
Reduction of marrow-cell release into blood
Correct Answer: Stimulation of neutrophil precursor proliferation and maturation
Explanation: Filgrastim acts as G-CSF, stimulating G-CSF receptors on neutrophil precursors and increasing their proliferation, maturation and marrow release.
MCQ 18
Question:
A patient treated with G-CSF after chemotherapy shows rapid neutrophil recovery. Subsequent blood counts rise well beyond the intended range. Which pharmacological effect best explains this finding?
Options:
Selective suppression of lymphocytes
Inhibition of neutrophil marrow release
Reduction of granulocyte survival
Excessive stimulation of leukocyte production
Suppression of hematopoietic progenitors
Correct Answer: Excessive stimulation of leukocyte production
Explanation: Because G-CSF drives granulocytic production, marked pharmacological stimulation can produce an excessive rise in circulating leukocytes.
MCQ 19
Question:
A patient undergoing evaluation for an allergic disorder has a selective rise in one granulocyte population. Which leukocyte is most closely associated with this type of response?
Options:
Eosinophil
Monocyte
Plasma cell
Neutrophil
Lymphocyte
Correct Answer: Eosinophil
Explanation: Eosinophils are granulocytes particularly associated with allergic responses and defense against parasitic infections.
MCQ 20
Question:
During an inflammatory response, a circulating leukocyte leaves the bloodstream and enters tissue, where it differentiates into a macrophage. Which circulating cell is the immediate precursor?
Options:
Basophil
Eosinophil
Monocyte
Neutrophil
Plasma cell
Correct Answer: Monocyte
Explanation: Monocytes circulate in blood and can enter tissues, where they differentiate into macrophages that perform phagocytic and immune functions.